AEterna initiated by Global Crown at overweight

AEterna Zentaris Inc. coverage was initiated by Global Crown Capital analyst Kate Winkler at an overweight rating. AEterna Zentaris is a multi-faceted company with an extensive endocrine and oncology product pipeline, Global Crown said, and the sum of its parts exceeds its current market value. AEterna Zentaris shares Tuesday dipped $0.09, or 1.91%, to $4.61 on volume of 30,051 shares versus the three-month running average of 24,910 shares.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.